Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines and vaccines. Key products include Comirnaty (COVID-19 vaccine), Paxlovid (COVID-19 oral treatment), Prevnar family (pneumococcal vaccines), Vyndaqel family (transthyretin amyloid cardiomyopathy), and oncology products including antibody-drug conjugates acquired through Seagen. Pfizer operates across developed and emerging markets worldwide, with commercial operations spanning internal and alliance-based product portfolios.
expected 2026-08-14
| Name | Role | Period |
|---|---|---|
| Steve | Analyst, Scala TD Cowen | ? – present |
| Albert | Chairman of the Board, Chief Executive Officer, Bourla Pfizer Inc | ? – present |
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | PFE | discussed Regulation | |
| topic_mention | PFE | discussed Artificial Intelligence | |
| topic_mention | PFE | discussed Healthcare & Bio | |
| topic_mention | PFE | discussed Artificial Intelligence | |
| topic_mention | PFE | discussed Artificial Intelligence | |
| topic_mention | PFE | discussed Blockchain & Crypto | |
| topic_mention | PFE | discussed GPU & Accelerators | |
| topic_mention | PFE | discussed Networking | |
| topic_mention | PFE | discussed Regulation | |
| topic_mention | PFE | discussed Enterprise | |
| topic_mention | PFE | discussed Automotive | |
| topic_mention | PFE | discussed Healthcare & Bio | |
| topic_mention | PFE | discussed Platform & Ecosystem | |
| metric | PFE EPS | reported $1.36 | |
| metric | PFE EPS | reported $3.22 | |
| guidance | PFE | guided expectations for revenues and Adjusted diluted EPS while also returning $9.8 billion | |
| guidance | PFE | guided expect additional savings of $700 million | |
| guidance | PFE | guided expected $5.7 billion | |
| guidance | PFE | guided expect total company full year '26 revenues to be in the range of $59.5 billion | |
| guidance | PFE | guided expected to trend lower again in '26 with revenues of approximately $5 billion |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0000078003-26-000026 | EDGAR | 105K words |
| 2025-02-27 | 2024-12-31 | 0000078003-25-000054 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0000078003-24-000039 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0000078003-23-000024 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0000078003-22-000027 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0000078003-21-000038 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-28 | 0000078003-26-000095 | EDGAR | — |
| 2026-05-05 | 2026-03-29 | 0000078003-26-000054 | EDGAR | — |
| 2025-11-04 | 2025-09-28 | 0000078003-25-000150 | EDGAR | 42K words |
| 2025-08-05 | 2025-06-29 | 0000078003-25-000138 | EDGAR | — |
| 2025-05-05 | 2025-03-30 | 0000078003-25-000114 | EDGAR | — |
| 2024-11-04 | 2024-09-29 | 0000078003-24-000191 | EDGAR | — |
| 2024-08-05 | 2024-06-30 | 0000078003-24-000166 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000078003-24-000107 | EDGAR | — |
| 2023-11-08 | 2023-10-01 | 0000078003-23-000115 | EDGAR | — |
| 2023-08-09 | 2023-07-02 | 0000078003-23-000088 | EDGAR | — |
| 2023-05-10 | 2023-04-02 | 0001628280-23-017196 | EDGAR | — |
| 2022-11-09 | 2022-10-02 | 0000078003-22-000101 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0000078003-26-000094 | EDGAR | — |
| 2026-06-18 | 0000078003-26-000087 | EDGAR | — |
| 2026-06-18 | 0000078003-26-000085 | EDGAR | — |
| 2026-05-05 | 0000078003-26-000053 | EDGAR | — |
| 2026-04-27 | 0000078003-26-000044 | EDGAR | — |
| 2026-02-03 | 0000078003-26-000005 | EDGAR | 18K words |
| 2025-12-16 | 0000078003-25-000167 | EDGAR | — |
| 2025-11-21 | 0001193125-25-291406 | EDGAR | — |
| 2025-11-13 | 0000078003-25-000159 | EDGAR | — |
| 2025-11-04 | 0000078003-25-000149 | EDGAR | — |
103 total filings indexed. 75 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | PFE Earnings Call Transcript | |
| — | PFE Earnings Call Transcript | |
| — | Q1 FY2026 | PFE Q1 FY2026 Earnings Call Transcript |
| — | Q4 FY2025 | PFE Q4 FY2025 Earnings Call Transcript |
| — | Q4 FY2025 | PFE Q4 FY2025 Earnings Call Transcript |
| — | Q4 FY2025 | PFE Q4 FY2025 Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000078003 |
| Ticker | PFE |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | New York, NY |
| Website | https://www.pfizer.com |
| Listed | 1951-06-22 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PFE (~200 tokens, structured JSON with cryptographic provenance)